(Total Views: 273)
Posted On: 12/20/2017 7:16:29 PM
Post# of 11803
No, this is NOT "the issue here".
If one follows the link backward, the issue was Weaver's post#3198
where he stated revenue projections for specific items:
Revenue projections from recent PRs for products
annually
Genprecis Diabetes type 1 $110m
type 2 $155m
Genultimate,Gensure,
Genchoice $100m
Genaccord $ 82m
total $447m
risk it replied with post #3199 where he stated:
"Only 446M short."
The "issue" was referencing only the above stated products by Weaver.
You changed the "issue" to include a multitude of :
"goals/tasks/events/projects/announcements"
"There have been multiple goals/tasks/events/projects/announcements that have been stated in the Quarterlies and then disappeared off the radar"
You may have other issues (I am sure) but that was definitely not the
Genprecis Diabetes type 1 $110m
type 2 $155m
Genultimate,Gensure,
Genchoice $100m
Genaccord $ 82m
total $447m
issue to which you responded.
If one follows the link backward, the issue was Weaver's post#3198
where he stated revenue projections for specific items:
Revenue projections from recent PRs for products
annually
Genprecis Diabetes type 1 $110m
type 2 $155m
Genultimate,Gensure,
Genchoice $100m
Genaccord $ 82m
total $447m
risk it replied with post #3199 where he stated:
"Only 446M short."
The "issue" was referencing only the above stated products by Weaver.
You changed the "issue" to include a multitude of :
"goals/tasks/events/projects/announcements"
"There have been multiple goals/tasks/events/projects/announcements that have been stated in the Quarterlies and then disappeared off the radar"
You may have other issues (I am sure) but that was definitely not the
Genprecis Diabetes type 1 $110m
type 2 $155m
Genultimate,Gensure,
Genchoice $100m
Genaccord $ 82m
total $447m
issue to which you responded.
(0)
(0)
